Epimedium Prenylflavonoid (EP) Extract for Osteoporosis and Cardiovascular Disease

NCT02931305 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Osteoporosis
Cardiovascular Disease

Interventions

DRUG: Epimedium Prenylflavonoids Extract
DRUG: Placebo

Sponsor

National University Hospital, Singapore